8622 — Joyzyme Share News
0.000.00%
Last trade - 00:00- HK$115.98m
- HK$73.19m
- CNY28.28m
Brief: Huakang Biomedical Says Placing Agreements Dated 20 June And 8 July Have Lapsed
Brief: Huakang Biomedical To Place On A Best Effort Basis, Up To 30 Million Placing Shares
Brief: Huakang Biomedical Sees Loss Attributable Of About RMB4.2 Million For Year
Brief: Huakang Biomedical Holdings Clarifies Media Reports Concerning Acquisition Of Co
Brief: Huakang Biomedical Sees A Loss Attributable Of About Rmb2.3 Million For Nine Months
Brief: Huakang Biomedical Sees A Loss Attributable Of About RMB1.1 Million For Three Months
Brief: Huakang Biomedical Sees Loss Attributable Of About RMB 6.6 Mln For 9 Months
Brief: Smartac Group China Announces Shareholders’ Agreement Of Smartronic Ltd
Brief: Huakang Biomedical Holdings Co Sees Qtrly Loss Attributable Of About Rmb2.8 Mln
Brief: Smartac Group China Holdings Announces MoU To Form JV Co In Hong Kong
Brief: Huakang Biomedical Holdings Says Jiaming Appointed As Executive Director
Brief: Huakang Biomedical Holdings Says Deloitte Touche Tohmatsu Resigned As Auditor Of Co
Brief: Huakang Biomedical Says Unit Enters MoU With JV Partner To Establish JV Co In Hong Kong
Brief: Huakang Biomedical Holdings Expects About 12.5% Decrease In Revenue For Nine Months
Brief: Huakang Biomedical Holdings Is Expected To Record A Decrease In Revenue For Six Months
China's Wuxi Apptec makes subdued Hong Kong debut